May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
H2 receptor blockade does not alter the ocular hemodynamic effects of histamine in healthy subjects.: 0
Author Affiliations & Notes
  • C. Zawinka
    Dept.of Clinical Pharmacology, Universitiy of Vienna, Vienna, Austria
  • H. Resch
    Dept.of Clinical Pharmacology, Universitiy of Vienna, Vienna, Austria
  • G. Weigert
    Dept.of Clinical Pharmacology, Universitiy of Vienna, Vienna, Austria
  • S. Lung
    Dept.of Clinical Pharmacology, Universitiy of Vienna, Vienna, Austria
  • L. Schmetterer
    Dept.of Clinical Pharmacology, Universitiy of Vienna, Vienna, Austria
  • G. Garhofer
    Dept.of Clinical Pharmacology, Universitiy of Vienna, Vienna, Austria
  • Footnotes
    Commercial Relationships  C. Zawinka, None; H. Resch, None; G. Weigert, None; S. Lung, None; L. Schmetterer, None; G. Garhofer, None.
  • Footnotes
    Support  FWF grant No P16514
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2615. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      C. Zawinka, H. Resch, G. Weigert, S. Lung, L. Schmetterer, G. Garhofer; H2 receptor blockade does not alter the ocular hemodynamic effects of histamine in healthy subjects.: 0 . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2615.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Intravenous histamine causes an increase in choroidal blood flow and retinal vessel diameters in healthy subjects. The mechanism underlying this effect remains, however, to be elucidated. In the present study we hypothesized that H2 receptor blockade alters the hemodynamic effects of histamine in the choroid and the retina. Methods: Fourteen healthy male subjects partizipated in this randomized, placebo–controlled two–way cross–over study. Histamine (0.32 mg/kg/min over 30 minutes) was infused intravenously in the absence (NaCl infusion as placebo) or presence of the H2 receptor blocker cimetidine (2.3 mg/min over 50 minutes). The infusion of cimetidine or placebo was started 20 minutes prior to the histamine infusion. Ocular hemodynamic parameters, blood pressure and intraocular pressure (IOP) were measured before drug administration, after infusion of cimetidine or placebo and after co–infusion of histamine. Subfoveal choroidal blood flow (CHBF) was measured with laser Doppler flowmetry. Retinal arterial and venous diameters (AD, VD) were measured with a Retinal Vessel Analyzer. Retinal blood velocity (VEL) was assessed with bi–directional laser Doppler velocimetry. Results: None of the administered drugs altered blood pressure or IOP. Hisatmine increased CHBF (+15%, p < 0.001), VD (+3.5%, p < 0.001), AD (+2.2%, p = 0.031), but did not change VEL. Cimetidine alone had no significant effect on ocular hemodynamic parameters. In addition, cimetidine did not modify the effects of histamine on CHBF (p = 0.233 versus placebo), VD (p = 0.633 versus placebo) and AD (p = 0.113 versus placebo). Conclusions: The present data confirm that histamine increases choroidal blood flow and retinal vessel diameters in vivo. This ocular vasodilator effect of histamine is, however, not altered by H2 receptor blockade. Whether the increase in blood flow is mediated via H1 receptors or by other hitherto unidentified mechanisms remains to be elucidated.

Keywords: blood supply • neurotransmitters/neurotransmitter systems • choroid 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×